Glioma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. For patients who can understand and voluntarily sign the informed consent form, the informed consent form must be signed before the implementation of any procedure specified in the trial; 2. The patients who were diagnosed as glioma by CT and MRI, or were diagnosed as glioma by biopsy or histopathology after operation, did not receive chemotherapy and radiotherapy before operation; 3. Laboratory test indexes must meet the corresponding requirements: hematological function, kidney and liver function, total bilirubin, etc., without diabetes, hypertension, heart disease and other basic diseases; 4. Patients must be willing and able to complete the study procedure and follow-up examination; 5. Patients over 18 years old.
Exclusion criteria
Exclusion criteria: 1. Patients with severe infection or medical diseases can not participate in the study or affect their compliance with the protocol, including but not limited to uncontrollable hypertension, or cardiovascular disease, myocardial infarction, unstable angina pectoris, etc; 2. Patients with previous or concomitant malignancies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gene; | — |
Countries
China
Contacts
The First Affiliated Hospital of Kunming Medical University